Literature DB >> 18257030

Physical characterization of clostridium difficile toxins and toxoids: effect of the formaldehyde crosslinking on thermal stability.

Maya S Salnikova1, Sangeeta B Joshi, J Howard Rytting, Michel Warny, C Russell Middaugh.   

Abstract

Nosocomial diarrhea and pseudomembranous colitis causing toxins A and B from Clostridium difficile were studied at pH 5-8 and over the temperature range of 10-85 degrees C. The proteins were crosslinked with formaldehyde to inactivate them to toxoid forms and permit their use as vaccines. Structural changes and aggregation behavior were monitored with circular dichroism, intrinsic and extrinsic (ANS) fluorescence spectroscopy, turbidity measurements, high-resolution UV absorbance spectroscopy and dynamic light scattering. The combined results were summarized in empirical phase diagrams. Toxins A and B had similar secondary structure with a combination of helical, beta-sheet and unordered character and were partially unfolded at pH 5-5.5. Upon heating, toxin A at all pH values partially unfolded at approximately 45 degrees C and formed insoluble aggregates at approximately 50 degrees C. Toxin B partially unfolded at approximately 40 degrees C, and upon heating to approximately 50 degrees C precipitated at pH 5.0-6.0 and formed soluble aggregates at pH 6.5-7.5. The thermal stability of the toxins was pH-dependent with the proteins more thermally stable at higher pH. Similar studies of formaldehyde crosslinked toxoids A and B revealed enhanced thermal stability, in which secondary and tertiary structure changes as well aggregation were delayed by about 10 degrees C. These studies reveal both similarities and differences between C. difficile toxins A and B and demonstrate the stabilizing effect of formaldehyde crosslinking on the thermal stability of their corresponding toxoids.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18257030     DOI: 10.1002/jps.21261

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  9 in total

Review 1.  A rational, systematic approach for the development of vaccine formulations.

Authors:  Garry L Morefield
Journal:  AAPS J       Date:  2011-02-23       Impact factor: 4.009

Review 2.  Multidimensional methods for the formulation of biopharmaceuticals and vaccines.

Authors:  Nathaniel R Maddux; Sangeeta B Joshi; David B Volkin; John P Ralston; C Russell Middaugh
Journal:  J Pharm Sci       Date:  2011-06-06       Impact factor: 3.534

3.  Toll-like receptor 5-dependent immunogenicity and protective efficacy of a recombinant fusion protein vaccine containing the nontoxic domains of Clostridium difficile toxins A and B and Salmonella enterica serovar typhimurium flagellin in a mouse model of Clostridium difficile disease.

Authors:  Chandrabali Ghose; Janneke M Verhagen; Xinhua Chen; Jian Yu; Yaoxing Huang; Olivia Chenesseau; Ciarán P Kelly; David D Ho
Journal:  Infect Immun       Date:  2013-04-01       Impact factor: 3.441

4.  Neutralization of Clostridium difficile toxin A with single-domain antibodies targeting the cell receptor binding domain.

Authors:  Greg Hussack; Mehdi Arbabi-Ghahroudi; Henk van Faassen; J Glenn Songer; Kenneth K-S Ng; Roger MacKenzie; Jamshid Tanha
Journal:  J Biol Chem       Date:  2011-01-07       Impact factor: 5.157

5.  Biophysical and stabilization studies of the Chlamydia trachomatis mouse pneumonitis major outer membrane protein.

Authors:  Sumin Cai; Feng He; Hardeep S Samra; Luis M de la Maza; Maria E Bottazzi; Sangeeta B Joshi; C Russell Middaugh
Journal:  Mol Pharm       Date:  2009 Sep-Oct       Impact factor: 4.939

6.  Long-term stability of a vaccine formulated with the amphipol-trapped major outer membrane protein from Chlamydia trachomatis.

Authors:  H Eric Feinstein; Delia Tifrea; Guifeng Sun; Jean-Luc Popot; Luis M de la Maza; Melanie J Cocco
Journal:  J Membr Biol       Date:  2014-06-19       Impact factor: 1.843

7.  Development of a subunit vaccine for prevention of Clostridium difficile associated diseases: Biophysical characterization of toxoids A and B.

Authors:  Alexey Gribenko; Elena Severina; Maninder K Sidhu; Kathrin U Jansen; Bruce A Green; Yury V Matsuka
Journal:  Biochem Biophys Rep       Date:  2017-01-05

Review 8.  Vaccine Technologies and Platforms for Infectious Diseases: Current Progress, Challenges, and Opportunities.

Authors:  Majed Ghattas; Garima Dwivedi; Marc Lavertu; Mohamad-Gabriel Alameh
Journal:  Vaccines (Basel)       Date:  2021-12-16

9.  Regulation of Clostridium tetani Neurotoxin Expression by Culture Conditions.

Authors:  Jeroen L A Pennings; Eric Abachin; Raphaël Esson; Hennie Hodemaekers; Antoine Francotte; Jean-Baptiste Claude; Céline Vanhee; Sylvie Uhlrich; Rob J Vandebriel
Journal:  Toxins (Basel)       Date:  2022-01-02       Impact factor: 4.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.